NEW YORK, Aug. 19 (GenomeWeb News) - Nanogen disclosed in an SEC filing today that it has received a letter from the US Food and Drug Administration stating that it requires FDA approval to market its NanoChip microarray platform.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports
By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.
In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.
Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.